APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON AUGUST 8, 2024By ApyxMedical|2025-12-12T18:01:36+00:00July 25, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION LAUNCHES THE “RENEWING LIVES” GIVE-BACK CAMPAIGN PROVIDING TREATMENTS WITH RENUVION TO BENEFIT PHYSICAL APPEARANCE AND MENTAL HEALTHBy ApyxMedical|2025-12-12T18:03:58+00:00June 26, 2024|2024 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS; REAFFIRMS FULL YEAR 2024 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T18:04:30+00:00May 9, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES BOARD LEADERSHIP TRANSITIONBy ApyxMedical|2025-12-12T18:04:59+00:00May 9, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024By ApyxMedical|2025-12-12T18:05:38+00:00April 25, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMITBy ApyxMedical|2025-12-12T18:06:03+00:00April 11, 2024|2024 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T18:06:50+00:00March 21, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024By ApyxMedical|2025-12-12T18:07:17+00:00March 4, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETINGBy ApyxMedical|2025-12-12T18:07:44+00:00February 21, 2024|2024 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODYBy ApyxMedical|2025-12-12T18:08:11+00:00January 22, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 REVENUE RESULTSBy ApyxMedical|2025-12-12T18:12:35+00:00January 8, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION APPOINTS MATTHEW HILL AS CHIEF FINANCIAL OFFICERBy ApyxMedical|2025-12-12T18:13:02+00:00November 28, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES NEW DEBT FACILITY WITH PERCEPTIVE ADVISORSBy ApyxMedical|2025-12-12T18:58:20+00:00November 9, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL YEAR 2023 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T18:58:55+00:00November 9, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBERBy ApyxMedical|2025-12-12T18:59:25+00:00November 7, 2023|2023 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON NOVEMBER 9, 2023By ApyxMedical|2025-12-12T18:59:53+00:00October 2, 2023|2023 Shareholder News, J-Plasma, Renuvion|
